Literature DB >> 12663443

Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.

Stefan Faderl1, David Harris, Quin Van, Hagop M Kantarjian, Moshe Talpaz, Zeev Estrov.   

Abstract

High levels of cytokines are associated with a poor prognosis in acute myeloid leukemia (AML). However, cytokines may induce, on one hand, survival factor expression and cell proliferation and, on the other hand, expression of inhibitory signals such as up-regulation of suppressors of cytokine signaling (SOCS) and induce apoptotic cell death. Because blasts from patients with AML express high procaspase protein levels, we asked whether granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances procaspase protein production in AML cells. In the GM-CSF-responsive OCIM2 AML cell line, GM-CSF induced signal transducer and activator of transcription 5 (Stat 5) phosphorylation, up-regulated cyclin D2, and stimulated cell cycle progression. Concurrently, GM-CSF stimulated expression of SOCS-2 and -3 and of procaspases 2 and 3 and induced caspase 3 activation, poly(ADP[adenosine 5'-diphosphate]-ribose) polymerase (PARP) cleavage, and apoptotic cell death. The Janus kinase (Jak)-Stat inhibitor AG490 abrogated GM-CSF-induced expression of procaspase 3 and activation of caspase 3. Under the same conditions GM-CSF up-regulated production of BAX as well as Bcl-2, Bcl-XL, survivin, and XIAP. GM-CSF also increased procaspase 3 protein levels in OCI/AML3 and Mo7e cells, suggesting that this phenomenon is not restricted to a single leukemia cell line. Our data suggest that GM-CSF exerts a dual effect: it stimulates cell division but contemporaneously up-regulates Jak-Stat-dependent proapoptotic proteins. Up-regulation of procaspase levels in AML is thus a beacon for an ongoing growth-stimulatory signal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663443     DOI: 10.1182/blood-2002-06-1890

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.

Authors:  John B Schell; Kapil Bahl; Nina F Rose; Linda Buonocore; Meredith Hunter; Preston A Marx; Celia C LaBranche; David C Montefiori; John K Rose
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

2.  Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity.

Authors:  Trisha R Stankiewicz; F Alexandra Loucks; Emily K Schroeder; Marja T Nevalainen; Kenneth L Tyler; Klaus Aktories; Ron J Bouchard; Daniel A Linseman
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

3.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

4.  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.

Authors:  Catriona H M Jamieson; Jason Gotlib; Jeffrey A Durocher; Mark P Chao; M Rajan Mariappan; Marla Lay; Carol Jones; James L Zehnder; Stan L Lilleberg; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

5.  Usp18 promotes conventional CD11b+ dendritic cell development.

Authors:  Xiu-Li Cong; Miao-Chia Lo; Brian A Reuter; Ming Yan; Jun-Bao Fan; Dong-Er Zhang
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

6.  The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.

Authors:  Gheath Alatrash; Yoko Ono; Anna Sergeeva; Pariya Sukhumalchandra; Mao Zhang; Lisa S St John; Tian-Hui Yang; Kathryn Ruisaard; Paul M Armistead; Elizabeth A Mittendorf; Hong He; Na Qiao; Tania Rodriguez-Cruz; Shoudan Liang; Karen Clise-Dwyer; Eric D Wieder; Gregory Lizee; Sijie Lu; Jeffrey J Molldrem
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

7.  IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation.

Authors:  Hernan Roca; Matthew J Craig; Chi Ying; Zachary S Varsos; Paul Czarnieski; Ajjai S Alva; James Hernandez; David Fuller; Stephanie Daignault; Patrick N Healy; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

8.  At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.

Authors:  Uri Rozovski; David M Harris; Ping Li; Zhiming Liu; Ji Yuan Wu; Srdana Grgurevic; Stefan Faderl; Alessandra Ferrajoli; William G Wierda; Matthew Martinez; Srdan Verstovsek; Michael J Keating; Zeev Estrov
Journal:  J Immunol       Date:  2016-04-13       Impact factor: 5.422

9.  Mast cells condition dendritic cells to mediate allograft tolerance.

Authors:  Victor C de Vries; Karina Pino-Lagos; Elizabeth C Nowak; Kathy A Bennett; Carla Oliva; Randolph J Noelle
Journal:  Immunity       Date:  2011-10-28       Impact factor: 31.745

10.  Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.

Authors:  Sarah R Walmsley; Edwin R Chilvers; Alfred A Thompson; Kathryn Vaughan; Helen M Marriott; Lisa C Parker; Gary Shaw; Selina Parmar; Martin Schneider; Ian Sabroe; David H Dockrell; Marta Milo; Cormac T Taylor; Randall S Johnson; Christopher W Pugh; Peter J Ratcliffe; Patrick H Maxwell; Peter Carmeliet; Moira K B Whyte
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.